High prevalence of HBV genotype D in Syria and the clinical characteristics of hepatitis B e antigen-negative chronic hepatitis B

被引:14
|
作者
Antaki, N. [1 ]
Haffar, S. [2 ]
Deeb, S. Ali [3 ]
Assaad, F. [4 ]
Abou Harb, R. [2 ]
Zeibane, N. [5 ]
Nasserelddine, M. [6 ]
Ibrahim, N. [7 ]
Alhaj, N. [2 ]
Jabbour, E. [8 ]
Aaraj, R. [9 ]
Antaki, F. [10 ]
Kebbewar, K. [11 ]
机构
[1] St Louis Hosp, Dept Gastroenterol & Hepatol, Aleppo, Syria
[2] Mouassat Hosp, Dept Gastroenterol, Damascus, Syria
[3] Damascus Hosp, Dept Gastroenterol, Damascus, Syria
[4] Squelbiye Natl Hosp, Dept Gastroenterol, Squelbiye, Syria
[5] Med Ctr Hosp, Dept Gastroenterol, Hama, Syria
[6] Sweida Natl Hosp, Dept Gastroenterol, Sweida, Syria
[7] Omaya Hosp, Dept Gastroenterol, Damascus, Syria
[8] Tabiyate Hosp, Dept Gastroenterol, Latakia, Syria
[9] Homs Natl Hosp, Dept Gastroenterol, Homs, Syria
[10] Wayne State Univ, Dept Gastroenterol, John D Dingell VA Med Ctr, Detroit, MI USA
[11] St Louis Hosp, Dept Lab Med, Aleppo, Syria
来源
EPIDEMIOLOGY AND INFECTION | 2010年 / 138卷 / 01期
关键词
Genotype D; genotype distribution; hepatitis B; HBeAg negative; Syria; VIRUS GENOTYPES; NATURAL-HISTORY; LAMIVUDINE; INFECTION; FREQUENCY;
D O I
10.1017/S0950268809990288
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Hepatitis B virus (HBV) genotype D and hepatitis B e antigen (HBeAg) negative chronic hepatitis are the most prevalent in Mediterranean countries. No data have ever been published oil their prevalence in Syria, a country of intermediate endemicity for HBV. The aims of the current study were to determine the HBV genotype distribution in Syria, the prevalence of HBeAg-positive and HBeAg-negative chronic hepatitis and to analyse the clinical characteristics of each group. A total of 220 patients were included. Ninety-seven percent of the patients were of genotype D, and 72% were HBeAg negative. The HBeAg-negative patients were older, had a lower viral load, had more cirrhosis and the mode of contamination was known less than for HBeAg-positive patients. These findings have major implications in understanding the natural history of the infection and are of great relevance in the choice of therapy.
引用
收藏
页码:40 / 44
页数:5
相关论文
共 50 条
  • [1] Treatment of hepatitis B e antigen-negative chronic hepatitis B with lamivudine
    Rizzetto, M
    Marzano, A
    Lagget, M
    [J]. JOURNAL OF HEPATOLOGY, 2003, 39 : S168 - S171
  • [2] Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong
    Chan, HLY
    Leung, NWY
    Hussain, M
    Wong, ML
    Lok, ASF
    [J]. HEPATOLOGY, 2000, 31 (03) : 763 - 768
  • [3] Interferon therapy in hepatitis B e antigen-negative chronic hepatitis B
    Colli, A
    Massironi, S
    Anreoletti, M
    [J]. HEPATOLOGY, 2003, 38 (03) : 779 - 780
  • [4] Characteristics and course of chronic hepatitis B e antigen-negative infection
    Guardiola Arevalo, Antonio
    Gomez Rodriguez, Rafael
    Romero Gutierrez, Marta
    Gomez Moreno, Ana Zaida
    Garcia Vela, Almudena
    Sanchez Simon, Raquel
    Gomez Hernando, Cesar
    Andres Esteban, Eva Maria
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (02): : 59 - 69
  • [5] Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
    Hadziyannis, SJ
    Tassopoulos, NC
    Heathcote, EJ
    Chang, TT
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Goodman, Z
    Wulfsohn, MS
    Xiong, S
    Fry, J
    Brosgart, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09): : 800 - 807
  • [6] Interferon α treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B
    Manesis, EK
    Hadziyannis, SJ
    [J]. GASTROENTEROLOGY, 2001, 121 (01) : 101 - 109
  • [7] Treatment paradigms on hepatitis B e antigen-negative chronic hepatitis B patients
    Hadziyannis, Stephanos J.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (06) : 777 - 786
  • [8] Hepatitis B e antigen-negative chronic hepatitis B: Natural history and treatment
    Hadziyannis, SJ
    Papatheodoridis, GV
    [J]. SEMINARS IN LIVER DISEASE, 2006, 26 (02) : 130 - 141
  • [9] Interferon therapy in hepatitis B e antigen-negative chronic hepatitis B - Reply
    Lampertico, P
    Colombo, M
    [J]. HEPATOLOGY, 2003, 38 (03) : 780 - 780
  • [10] Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B
    Feld, Jordan J.
    Ayers, Melissa
    El-Ashry, Dahlia
    Mazzulli, Tony
    Tellier, Raymond
    Heathcote, E. Jenny
    [J]. HEPATOLOGY, 2007, 46 (04) : 1057 - 1070